Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G for PROKIDNEY CORP. Class A Common Stock (PROK).
- Disclosed ownership: 6%.
- Date of event: 31 Dec 2025.
MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G Report for PROKIDNEY CORP. Class A Common Stock (PROK)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Security
- PROKIDNEY CORP. Class A Common Stock
- Symbol
- PROK
- Shares outstanding
- 141,999,700 shares
- Disclosed Ownership
- 8,519,982 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Feb 2026, 14:11:38 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 6% ownership in PROKIDNEY CORP. Class A Common Stock (PROK) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2026, 14:11.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 6% | 8,519,982 | 0 | 8,247,740 | Chris O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Investment Management Inc. | 6% | 8,518,684 | 0 | 8,246,442 | Deidre A. Downes | Authorized Signatory, Morgan Stanley Investment Management Inc. |